Dismissing Muslim Brotherhood employees    Egypt taxes online companies    Egyptian launches trade missions to Central, West Africa    Egyptian filmmaker Sameh Alaa selected for Cannes short films' jury    Don't miss Sudanese singer Asia Madani's concert at Cervantes Institute    Saadi Youssef (1934-2021): The last communist    Egypt, France discuss methods of cooperation in tourism, antiquities    Egypt's annual urban inflation rises to 4.8% in May 2021: CBE    Iran presidential candidate urges better ties with West    Egypt's Health Minister discusses COVID-19 vaccines with COVAX official in Geneva    Egypt stresses need for clear Arab solidarity to reach agreement on GERD    Egypt hands documents to Italy refuting role of police officers in Regeni's murder    US death toll surpasses 600,000 from coronavirus    Egypt, Qatar agree on continuing consultations to advance bilateral relations    Ethiopia and the Horn of Africa    Tunisia allows 5,000 fans to attend Esperance-Ahly clash pending CAF approval    Former presidential candidate Abul-Fotouh to remain in custody despite release order, says Egypt's prosecution    Experts warn Delta variant on track to become dominant coronavirus strain in US    Afsha, Soliman give Ahly a boost ahead of Esperance clash    "Soul Water" signs MoU with "Evoqua Water Technologies" as their agent in Egypt    Egypt's stocks end red as benchmark EGX 30 falls 0.42% on Tuesday    30 international troupes take part in Egypt's 8th Festival of Drums and Traditional Arts    Environment Minister highlights Egypt's steps toward creating green economy    Top US adviser participates in Egypt's 'Decent Life' initiative    Egypt condemns recent Houthi's drone attack on Saudi school    Egypt, US discuss enhancing military cooperation    Emirates Air posts $5.5 bln loss as virus disrupts travel    Egyptian universities, educational institutes allocate EGP 57m to Gaza reconstruction    Denmark's Eriksen sends public thank you message from hospital    New Israel government vows change, but not for Palestinians    Egypt's Court of Cassation upholds death penalty to 3 Muslim Brotherhood leaders    Sudan to complain to Security Council of Ethiopian unilateral measures on GERD    APO Group, Getty Images make African press releases, images available globally    Egypt's Qalaa Holdings chairman banned from flying – Reuters    Italian film 'Mi chiamo Francesco Totti' wins BankGiro Loterij Audience Award at IFFR    Egypt development projects in South Sudan serve as role model in Africa: Irrigation minister    APO Group enters new exclusive agreement with Getty Images on African press releases and images    Defending champions Brazil hosts Copa America    France's Benzema eyes national team return    Egypt is on short list of partner countries for U.S. COVID-19 vaccines: embassy    Russia to resume charter flights to Egypt resorts in the coming days    Biden administration to send surplus U.S. COVID-19 vaccines to Egypt, several countries    Russia expects to resume charter flights to Egypt resorts in near future    Egypt's Sisi announces allocation of $500 million for reconstruction in war-wrecked Gaza    On International Museum Day, Egypt opens two new museums at Cairo Airport    Egypt's Ahly is establishing a new stadium, expected to be 'sports complex'    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    Veteran Egyptian journalist Makram Mohamed Ahmed passes away at 86    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

Rameda's new antiviral medication successfully opens up new export markets
Levant region has lion's share of group's export volumes in Q1 2021
Published in Daily News Egypt on 10 - 05 - 2021

The Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda), a leading pharmaceuticals manufacturer in Egypt, has reported its new antiviral medication successfully opened up new export markets for the company.
This included opening up new export markets in the Levant, which took the lion's share of the group's export volumes for the first quarter (Q1) of 2021.
CEO of Rameda Amr Morsy said, "After international restrictions related to the [novel coronavirus (COVID-19)] pandemic eased, combined with growing regional demand for Rameda's new antiviral medication for the treatment of COVID-19, the Group's export volume increased by 96.8% y-o-y to 0.7 million units in Q1 of 2021."
Morsy said that the antiviral medication's performance reflected positively on the company's export revenues, which recorded more than a four-fold increase y-o-y to EGP 22.7m in Q1 of 2021.
Meanwhile, Rameda saw a book top line growth of 17% year-on-year (y-o-y) to EGP 270.8m in Q1 of 2021, with profit after minority interest growing by 26% y-o-y to EGP 30.2m for the period.
The company's consolidated revenues grew by 16.5% y-o-y to EGP 270.8m on the back of the Group's optimised portfolio strategy. This was coupled with a ramp-up in sales of its new COVID-19 related antiviral products, Anviziram and Remdesivir, both domestically and internationally in Q1 of 2021.
Total volume sold, excluding toll sales, declined by 10.6% y-o-y to 14.9m units in Q1 of 2021 on the back of a 27.9% y-o-y decrease in tender volumes, the Group's largest contributing segment in the quarter.
Rameda is currently completing the registration process to export its products to select Gulf Cooperation Council (GCC) and Eastern European markets. This is with the aim of expanding its operations and unlocking additional value for the Group and its stakeholders.
"We remain focused on bringing new products to the market and growing our comprehensive portfolio as well expanding our offering into new therapeutic areas and markets beyond our home borders," Morsy added. "This quarter, we added two new products to Rameda's growing portfolio, Doxytroler and Opranate."
He noted that in line with its portfolio optimisation strategy, the company expects the solid performance from Doxytroler and Opranate to support top line and gross margin growth within their therapeutic areas.

Clic here to read the story from its source.